United States · Platforms & data · Finviz

UPDATE -- Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study

Published by Finviz · United States 9 h ago

Supported The Michael J Fox Foundation for Parkinson's Research, Alzheimer's Research UK and LifeArc, the study targets earlier detection, prevention and treatment of Parkinson’s…

Read the full article on Finviz Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finviz.com)

Also worth reading

MarketBeat

BlossomHill Therapeutics (NASDAQ:BLSM) Reaches New 52-Week Low - Here's What Happened

Seeking Alpha

Clorox forecasts 3.5%-4.5% organic sales growth as input cost inflation rises to $240M

The Motley Fool

JAKKS Pacific: 3 Key Takeaways for Long-Term Investors

MarketWatch

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

Investing.com

Disney eyes thousands of layoffs, asks managers to target 20% savings, Bloomberg News reports

CNBC